DNM2 and glomerular disorder: In addition, several cytoskeletal proteins of RhoA upstream modulators are found to be involved in hereditary glomerular diseases (Schell & Huber, 2017), suggesting that inappropriate activation of RhoA is significant both physiologically and pathologically.